2006-2007 Mohnarin report: Bacterial distribution and resistance in urinary tract infections

Chinese Journal of Antibiotics

Volumn 33, Issue 10, 2008, Pages

  Gao, Lei ^a   Xiao, Yong Hong ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

2006 2007 year; Bacterial resistance surveillance; Mohnarin; Urinary tract infections

Indexed keywords

CEPHALOSPORIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CHINA; DISK DIFFUSION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; URINARY TRACT INFECTION;

EID: 57849133656     PISSN: 10018689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Katsumi S, Kazushi T, Hiroshi O, et al. Pathogen occurrence and antimicrobial susceptibility of urinary tract infection cases during a 20-year period (1983-2002) at a single institution in Japan [J]. Jpn J Infect Dis, 2005,58(1):303-308.
2. Sita N, Tvan M, Barteids AIM, et al. Urinary tract infections in general practice patients, diagnostic tests versus bacteriological culture [J]. J Antimicrob Chemother, 2006,57(5):955-958.
3. Laupland K B, Ross T, Pitout J D, et al. Community-onset urinary tract infections, a population-based assessment [J]. Infection, 2007,35(3):150-153.
4. Chinese source
5. Zhanel G G, Laing N M, Nichol K A. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS) [J]. J Antimicrob Chemother, 2003,52(3):382-388.
6. Chinese source
7. Chinese source
8. Chinese source
9. DeFrancesco M, Ravizzola G, Peroni L. Urinary tract infections in Brescia, Italy, etiology of uropathogens and antimicrobial resistance of common uropathogens [J]. Med Sci Monit, 2007,13(6):136-144.
10. Esther C, Veronica R, Mariona X, et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended spectrum β- lactamases [J]. J Antimicrob Chemother, 2006,57:780-783.
11. Kurutepe S, Surucuoglu S, Sezgin C, et al. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey [J]. Jpn J Infect Dis, 2005, 58(3):159-161.
12. Goettsch W, Vanpelt, W, Nagelkerke N, et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands [J]. J Antimicrob Chemother, 2000,46(2):223-228.
13. Zhanel G G, Hisanaga T L, Laing N M, et al. Antibiotic resistance in outpatient urinary isolates: Final results from the North American Urinary Tract Infection CollaborativeAlliance (NAUTICA) [J]. Int J Antimicrob Agents, 2005,26(6):380-388.
14. Rodríguez L F C, FrancoáL F, Gordillo U R M. Microorganisms isolated from outpatient urine samples and antimicrobial susceptibility over a 12-year period [J]. Rev Esp Quimioter, 2005,18(2):159-167.